Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today increasing demand from ...

Illumina, Inc. , a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeqtm i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to ...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia ...

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version 08.10.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this ...

Emergent said it is separately working on increasing the availability of its overdose reverser on site for businesses.

Pioneering Sustainable Solutions Across Diverse Industries Drive Market Growth.Rockville, MD , Oct. 09, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence ...

Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...

On 16 October 2024, KitNewCare will host its Innovation Challenge, an event designed to foster collaborative innovation towards achieving sustainability in kidney care. A new study by researchers ...

In recent times, the dental implants market is witnessing immense growth owing to the rising prevalence of oral and tooth loss problems. Nowadays, people are suffering from oral p ...

🗳️ School board elections: What to know 🏀 SDSU's impressive freshmen 🗳️ Voter guide: Propositions 🎃 20 haunted attractions in S.D. 🏙️ SD's best (and worst) architecture ...